Jake Peter Mann

12PUBLICATIONS
19CO-AUTHORS
Adolescent healthMedical biochemistry - lipidsEpigenetics (incl. genome methylation and epigenomics)Nanofabrication, growth and self assemblyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 30, 2026
European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction-associated steatotic liver disease.

|Feb 01, 2023
A mouse model of human mitofusin-2-related lipodystrophy exhibits adipose-specific mitochondrial stress and reduced leptin secretion.

Jake P Mann, Xiaowen Duan, Satish Patel

|Apr 27, 2022
A minority of somatically mutated genes in pre-existing fatty liver disease have prognostic importance in the development of NAFLD.

Jake P Mann, Matthew Hoare

|Apr 12, 2022
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms.

Christian A Hudert, Leon A Adams, Anna Alisi

|May 11, 2021
A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD.

Yu Ri Im, Harriet Hunter, Dana de Gracia Hahn

|Oct 27, 2020
Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.

Jake P Mann, Paul Carter, Matthew J Armstrong

Pageof 2

Frequent Collaborators

1 joint publications

Hong Kai Lim

1 joint publications

Raunak Rao

1 joint publications

Mrudula Utukuri

1 joint publications

Hesham K Abdelaziz